These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8885745)

  • 21. Peripartum thromboprophylaxis for homozygous and heterozygous FVL mutation carriers yields similar pregnancy outcome.
    Gat I; Dulitzki M; Schiff E; Sivan E; Simchen MJ
    Isr Med Assoc J; 2014 Feb; 16(2):96-100. PubMed ID: 24645228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Occurrence of gene mutations in factor V Leiden, prothrombin and methylenetetrahydrofolate reductase in patients with pre-eclampsia].
    Procházka M; Krcová V; Kudela M; Slavík L
    Ceska Gynekol; 2003 May; 68(3):162-6. PubMed ID: 12879654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe preeclampsia associated with coinheritance of factor V Leiden mutation and protein S deficiency.
    Kahn SR
    Obstet Gynecol; 1998 May; 91(5 Pt 2):812-4. PubMed ID: 9572171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of factor V Leiden mutation in severe pre-eclamptic Hungarian women.
    Nagy B; Tóth T; Rigó J; Karádi I; Romics L; Papp Z
    Clin Genet; 1998 Jun; 53(6):478-81. PubMed ID: 9712539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.
    Dizon-Townson D; Miller C; Sibai B; Spong CY; Thom E; Wendel G; Wenstrom K; Samuels P; Cotroneo MA; Moawad A; Sorokin Y; Meis P; Miodovnik M; O'Sullivan MJ; Conway D; Wapner RJ; Gabbe SG;
    Obstet Gynecol; 2005 Sep; 106(3):517-24. PubMed ID: 16135581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A promoter mutation in the tumor necrosis factor alpha gene is not associated with preeclampsia.
    Dizon-Townson DS; Major H; Ward K
    J Reprod Immunol; 1998 Apr; 38(1):55-61. PubMed ID: 9616877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe preeclampsia.
    Gerhardt A; Goecke TW; Beckmann MW; Wagner KJ; Tutschek B; Willers R; Bender HG; Scharf RE; Zotz RB
    J Thromb Haemost; 2005 Apr; 3(4):686-91. PubMed ID: 15842353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preeclampsia is associated with a reduced response to activated protein C.
    Lindoff C; Ingemarsson I; Martinsson G; Segelmark M; Thysell H; Astedt B
    Am J Obstet Gynecol; 1997 Feb; 176(2):457-60. PubMed ID: 9065198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HELLP syndrome and factor V Leiden.
    Bozzo M; Carpani G; Leo L; Marcozzi S; Sacchi E; Moroni G; Pardi G
    Eur J Obstet Gynecol Reprod Biol; 2001 Mar; 95(1):55-8. PubMed ID: 11267721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor V Leiden mutation and its impact on pregnancy complications.
    Hammerová L; Chabada J; Drobný J; Bátorová A
    Acta Medica (Hradec Kralove); 2011; 54(3):117-21. PubMed ID: 22250481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
    DeSancho MT; Berlus N; Christos PJ; Rand J
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombophilic mutations in pre-eclampsia and pregnancy-induced hypertension.
    Omar SZ; Qvist R; Khaing SL; Muniandy S; Bhalla S
    J Obstet Gynaecol Res; 2008 Apr; 34(2):174-8. PubMed ID: 18412778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia.
    Fabbro D; D'Elia AV; Spizzo R; Driul L; Barillari G; Di Loreto C; Marchesoni D; Damante G
    Gynecol Obstet Invest; 2003; 56(1):17-22. PubMed ID: 12867763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fetal genotype for specific inherited thrombophilias is not associated with severe preeclampsia.
    Stanley-Christian H; Ghidini A; Sacher R; Shemirani M
    J Soc Gynecol Investig; 2005 Apr; 12(3):198-201. PubMed ID: 15784506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.
    Rahimi Z; Vaisi-Raygani A; Nagel RL; Muniz A
    J Thromb Thrombolysis; 2008 Jun; 25(3):288-92. PubMed ID: 17619828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis.
    Dudding TE; Attia J
    Thromb Haemost; 2004 Apr; 91(4):700-11. PubMed ID: 15045131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic thrombophilias and preeclampsia: a meta-analysis.
    Lin J; August P
    Obstet Gynecol; 2005 Jan; 105(1):182-92. PubMed ID: 15625161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Thrombophilic mutation by women with serious pregnancy complications].
    Vavrinková B; Binder T; Hadacová I; Hrachovinová I; Salaj P; Hruda M
    Ceska Gynekol; 2012 Apr; 77(2):171-4. PubMed ID: 22702078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Screening for pre-eclampsia in a low-risk population at 24 weeks: uterine artery Doppler flow velocimetry and genetic variants of factor V, prothrombin and methylenetetrahydrofolate reductase].
    Driul L; Damante G; D'Elia A; Springolo F; Ianni A; Di Leonardo C; Angelini M; Marchesoni D
    Minerva Ginecol; 2004 Oct; 56(5):385-90. PubMed ID: 15531855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of factor V Leiden carriage on maternal and fetal health.
    Bloomenthal D; von Dadelszen P; Liston R; Magee L; Tsang P
    CMAJ; 2002 Jul; 167(1):48-54. PubMed ID: 12137081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.